PSquared Asset Management AG — 13F Holdings & Portfolio
CIK 1623624 · latest 13F-HR filed 2026-05-14
PSquared Asset Management AG manages $287.4M in 13F-reported U.S. long-equity assets across 15 reported positions as of its 2026-03-31 13F-HR filing. Its largest disclosed positions are WBD (15.89%), IHS (12.44%), SLSR (12.27%). Quarter over quarter (versus its 2025-12-31 filing) the fund opened 8 new positions, exited 5, added to 5, and trimmed 0.
AUM is the long-equity portion reported on Form 13F-HR. Excludes short positions, cash, foreign holdings, and non-13F assets. For informational purposes only — not investment advice.
$287.4M
Long-equity book
15
Distinct positions
2026-03-31
Filed 2026-05-14
+8 / −5 / ↑5 / ↓0
vs 2025-12-31
| Name | Title / Status | Ownership | Type |
|---|
Top Adds (vs prior quarter)
- SOLARIS RES INC$3.5M +11.0%
- ABIVAX SA$1.6M +839.5%
- CHART INDS INC$1.5M +6.4%
- AMICUS THERAPEUTICS INC$971.8K +6.5%
- PROASSURANCE CORP$733.4K +8.8%
New Positions
- IHS HOLDING LIMITED$35.7M
- HOLOGIC INC$30.7M
- ALLIED GOLD CORP$22.9M
- PENUMBRA INC$14.0M
- REVOLUTION MEDICINES INC$13.4M
Exited Positions
- COMPASS INC$18.5M
- BLACKLINE INC$16.8M
- DIGITALBRIDGE GROUP INC$12.9M
- AVIDITY BIOSCIENCES INC$12.1M
- FORWARD AIR CORP$4.4M
Rows tagged Call or Put are options positions, not stock. Per SEC Form 13F-HR, Value shows the notional value of the underlying (shares covered × underlying price), not the option premium. Shares is the number of underlying shares covered (divide by 100 for contract count).
| # | Issuer | Symbol | CUSIP | Value | Weight | Shares | Type |
|---|---|---|---|---|---|---|---|
| 1 | WARNER BROS DISCOVERY INC | WBD | 934423104 | $45.7M | 15.89% | 1,663,164 | SH |
| 2 | IHS HOLDING LIMITED | IHS | G4701H109 | $35.7M | 12.44% | 4,343,787 | SH |
| 3 | SOLARIS RES INC | SLSR | 83419D201 | $35.3M | 12.27% | 4,084,315 | SH |
| 4 | HOLOGIC INC | HOLX | 436440101 | $30.7M | 10.68% | 405,920 | SH |
| 5 | NORFOLK SOUTHN CORP | NSC | 655844108 | $27.7M | 9.62% | 96,385 | SH |
| 6 | CHART INDS INC | GTLS | 16115Q308 | $24.3M | 8.45% | 117,407 | SH |
| 7 | ALLIED GOLD CORP | AAUC | 01921D204 | $22.9M | 7.97% | 740,000 | SH |
| 8 | AMICUS THERAPEUTICS INC | FOLD | 03152W109 | $15.9M | 5.54% | 1,101,228 | SH |
| 9 | PENUMBRA INC | PEN | 70975L107 | $14.0M | 4.89% | 42,785 | SH |
| 10 | REVOLUTION MEDICINES INC | RVMD | 76155X100 | $13.4M | 4.68% | 138,290 | SH |
| 11 | PROASSURANCE CORP | PRA | 74267C106 | $9.1M | 3.17% | 368,059 | SH |
| 12 | ARCELLX INC | ACLX | 03940C100 | $6.3M | 2.21% | 55,251 | SH |
| 13 | OLAPLEX HLDGS INC | OLPX | 679369108 | $2.9M | 1.00% | 1,415,716 | SH |
| 14 | ABIVAX SA | ABVX | 00370M103 | $1.8M | 0.63% | 16,200 | SH |
| 15 | STRUCTURE THERAPEUTICS INC | GPCR | 86366E106 | $1.7M | 0.59% | 35,000 | SH |
| Period | Filed | AUM | Holdings | Accession |
|---|---|---|---|---|
| 2026-03-31 | 2026-05-14 | $287.4M | 15 | 0000945621-26-000698 |
| 2025-12-31 | 2026-02-13 | $213.9M | 12 | 0000945621-26-000319 |
| 2025-09-30 | 2025-11-13 | $126.0M | 9 | 0000945621-25-001083 |